148 related articles for article (PubMed ID: 25997995)
1. miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy.
Yin W; Nie Y; Zhang Z; Xie L; He X
Oncol Rep; 2015 Jul; 34(1):368-74. PubMed ID: 25997995
[TBL] [Abstract][Full Text] [Related]
2. Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib.
Mao K; Zhang J; He C; Xu K; Liu J; Sun J; Wu G; Tan C; Zeng Y; Wang J; Xiao Z
Cancer Lett; 2014 Oct; 352(2):245-52. PubMed ID: 25034398
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1.
Ou Y; Zhai D; Wu N; Li X
Gene; 2015 Nov; 572(1):116-122. PubMed ID: 26143754
[TBL] [Abstract][Full Text] [Related]
4. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
Qin J; Luo M; Qian H; Chen W
Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
[TBL] [Abstract][Full Text] [Related]
5. Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells.
Jiang C; Long J; Liu B; Xie X; Kuang M
Biomed Res Int; 2015; 2015():572738. PubMed ID: 26078955
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-101 sensitizes hepatocellular carcinoma cells to doxorubicin-induced apoptosis via targeting Mcl-1.
He H; Tian W; Chen H; Deng Y
Mol Med Rep; 2016 Feb; 13(2):1923-9. PubMed ID: 26718267
[TBL] [Abstract][Full Text] [Related]
7. Imperatorin acts as a cisplatin sensitizer via downregulating Mcl-1 expression in HCC chemotherapy.
Hu J; Xu C; Cheng B; Jin L; Li J; Gong Y; Lin W; Pan Z; Pan C
Tumour Biol; 2016 Jan; 37(1):331-9. PubMed ID: 26219890
[TBL] [Abstract][Full Text] [Related]
8. MiR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer.
Zhang R; Li Y; Dong X; Peng L; Nie X
Med Oncol; 2014 Dec; 31(12):347. PubMed ID: 25416050
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell.
Xu N; Zhang J; Shen C; Luo Y; Xia L; Xue F; Xia Q
Biochem Biophys Res Commun; 2012 Jul; 423(4):826-31. PubMed ID: 22713463
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells.
Yang Y; Li M; Chang S; Wang L; Song T; Gao L; Hu L; Li Z; Liu L; Yao J; Huang C
Mol Med Rep; 2014 Nov; 10(5):2643-8. PubMed ID: 25174704
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells.
Miyata M; Morishita A; Sakamoto T; Katsura A; Kato K; Nishioka T; Toyota Y; Fujita K; Maeda E; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Fujiwara S; Nishiyama N; Iwama H; Himoto T; Hirashima M; Masaki T
Int J Oncol; 2015 Aug; 47(2):535-42. PubMed ID: 26060089
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.
Zhuang Q; Zhou T; He C; Zhang S; Qiu Y; Luo B; Zhao R; Liu H; Lin Y; Lin Z
J Exp Clin Cancer Res; 2016 Apr; 35():67. PubMed ID: 27074866
[TBL] [Abstract][Full Text] [Related]
13. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM
J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099
[TBL] [Abstract][Full Text] [Related]
14. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.
El Tayebi HM; Hosny KA; Esmat G; Breuhahn K; Abdelaziz AI
FEBS Lett; 2012 Sep; 586(19):3309-16. PubMed ID: 22819824
[TBL] [Abstract][Full Text] [Related]
15. miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.
Zhang Y; Zheng D; Xiong Y; Xue C; Chen G; Yan B; Ye Q
FEBS Lett; 2014 May; 588(10):1913-20. PubMed ID: 24704686
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-7 upregulates Cullin 5 (CUL5) to facilitate G1/S transition in human hepatocellular carcinoma cells.
Ma C; Qi Y; Shao L; Liu M; Li X; Tang H
IUBMB Life; 2013 Dec; 65(12):1026-34. PubMed ID: 24339204
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-363-mediated downregulation of S1PR1 suppresses the proliferation of hepatocellular carcinoma cells.
Zhou P; Huang G; Zhao Y; Zhong D; Xu Z; Zeng Y; Zhang Y; Li S; He F
Cell Signal; 2014 Jun; 26(6):1347-54. PubMed ID: 24631531
[TBL] [Abstract][Full Text] [Related]
18. miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1.
Long J; Ji Z; Jiang K; Wang Z; Meng G
Biomed Res Int; 2015; 2015():373574. PubMed ID: 26526790
[TBL] [Abstract][Full Text] [Related]
19. miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells.
Xu Y; An Y; Wang Y; Zhang C; Zhang H; Huang C; Jiang H; Wang X; Li X
Oncol Rep; 2013 May; 29(5):2019-24. PubMed ID: 23483142
[TBL] [Abstract][Full Text] [Related]
20. MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway.
Yang Y; Yang Z; Zhang R; Jia C; Mao R; Mahati S; Zhang Y; Wu G; Sun YN; Jia XY; Aimudula A; Zhang H; Bao Y
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34096570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
